Concepedia

Adel Jebar

AJ

Statistics

Publications

4

Citations

524

H-Index

4

Active since

2005

Affiliations

Institute of Cancer Research(Current)

University of Surrey

Oncolytics Biotech (Canada)

Adel Jebar is an author at Institute of Cancer Research specializing in medicine, pharmacology, and antiviral signaling pathways.

Publications per year

2005–2015

4

Publications

4

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma

Adel Jebar, Carolyn D. Hurst, Darren C. Tomlinson et al. · Oncogene · 2005 · 331 citations

Medicine, Genetics, Molecular Genetics +14

Interpretation of Medication Pictograms by Adults in the UK

Peter Knapp, David K. Raynor, Adel Jebar et al. · Annals of Pharmacotherapy · 2005 · 77 citations

Pharmacy, Geriatric Medicine, Diagnostic Reasoning +13

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway

Katie Twigger, Victoria Roulstone, Joan Kyula et al. · BMC Cancer · 2012 · 62 citations · Full text

Medicine, Oncology, Pharmacology +11

BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress

Victoria Roulstone, Malin Pedersen, Joan Kyula et al. · Molecular Therapy · 2015 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4